1. Home
  2. MLYS vs CSV Comparison

MLYS vs CSV Comparison

Compare MLYS & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • CSV
  • Stock Information
  • Founded
  • MLYS 2019
  • CSV 1991
  • Country
  • MLYS United States
  • CSV United States
  • Employees
  • MLYS N/A
  • CSV N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • CSV Other Consumer Services
  • Sector
  • MLYS Health Care
  • CSV Consumer Discretionary
  • Exchange
  • MLYS Nasdaq
  • CSV Nasdaq
  • Market Cap
  • MLYS 634.6M
  • CSV 616.5M
  • IPO Year
  • MLYS 2023
  • CSV 1996
  • Fundamental
  • Price
  • MLYS $9.24
  • CSV $40.22
  • Analyst Decision
  • MLYS Strong Buy
  • CSV Strong Buy
  • Analyst Count
  • MLYS 2
  • CSV 2
  • Target Price
  • MLYS $30.00
  • CSV $45.00
  • AVG Volume (30 Days)
  • MLYS 266.6K
  • CSV 95.2K
  • Earning Date
  • MLYS 11-11-2024
  • CSV 02-19-2025
  • Dividend Yield
  • MLYS N/A
  • CSV 1.12%
  • EPS Growth
  • MLYS N/A
  • CSV 15.90
  • EPS
  • MLYS N/A
  • CSV 2.23
  • Revenue
  • MLYS N/A
  • CSV $405,332,000.00
  • Revenue This Year
  • MLYS N/A
  • CSV $6.46
  • Revenue Next Year
  • MLYS N/A
  • CSV $4.11
  • P/E Ratio
  • MLYS N/A
  • CSV $17.98
  • Revenue Growth
  • MLYS N/A
  • CSV 7.34
  • 52 Week Low
  • MLYS $8.28
  • CSV $22.84
  • 52 Week High
  • MLYS $16.91
  • CSV $42.13
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 32.12
  • CSV 56.43
  • Support Level
  • MLYS $8.60
  • CSV $39.67
  • Resistance Level
  • MLYS $9.97
  • CSV $40.38
  • Average True Range (ATR)
  • MLYS 0.88
  • CSV 0.92
  • MACD
  • MLYS -0.31
  • CSV 0.00
  • Stochastic Oscillator
  • MLYS 13.25
  • CSV 72.44

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum crypts, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

Share on Social Networks: